For guidelines on policy and submission across our journals, please click on the links below:
Planning your research
Writing your paper
Choosing a journal
Submitting your paper
Promoting your paper
Authors can choose to have their article published Open Access for a fee of £1,950 (plus applicable VAT).
We do not offer refunds for Open Access once articles have been published.
The Journal of NeuroInterventional Surgery welcomes submissions from researchers, educators, and practitioners who are active in the field. The following article types will be considered:
Original clinical research
Letters to the editor
Images with commentaries (outstanding images may be considered for publication on the journal’s front cover)
Please read this section carefully before beginning to submit your paper
JNIS operates double-blind peer review which requires authors to submit two versions of their manuscript file:
Version 1 (To be uploaded as the Manuscript File): This file should be anonymous and should NOT include:
Any author names
Author institution details
Author contact details
Competing interests (if declared)
Ethics approval statements that refer to your institution
This file will be automatically converted to PDF once uploaded through the online submission system (ScholarOne) and will be made available to the reviewers.
Version 2 (To be uploaded as a Supplemental File): This file should include the manuscript text and all the information omitted from Version 1:
Full author and institution details for all authors
Competing Interests (please list as ‘none declared’ if not applicable)
Ethics approval statements
This file will only be accessed by the Editor and the Editorial Staff.
BMJ Journals, including JNIS, follows guidelines on editorial independence produced by the World Association of Medical Editors, the code on good publication practice produced by the Committee on Publication Ethics, and the EQUATOR network resource centre for good research reporting.
Editors reserve the right to return manuscripts that do not meet these guidelines.
Authors (or their employers) retain copyright in the article; the publishers require an exclusive licence (except for certain government employees who cannot grant this) that allows us to publish the article in JNIS (including any derivative products) and any other BMJ Publishing Group products, and allows us to sub-licence such rights and exploit all subsidiary rights.
We ask the corresponding author to grant this licence on behalf of all authors as shown in the Author Licence Form.
If you are not a native English speaker and would like assistance with your article there is a professional editing service available.
Submitting authors may find it useful to take a look at BMJ’s pre-submission checklist, which offers an overview of the basic, common requirements for submitting to BMJ journals. However, please remember that this checklist does not cover any additional, Journal-specific requirements such as those listed elsewhere on this “Instructions for Authors” page.
Authors submitting papers reporting original data (for example, controlled trials and intervention studies) should not exceed a limit of 3000 words, four figures and/or tables, and 30 references, and should provide a structured abstract of no more than 250 words. If after removing redundancy and repetition your article exceeds these limits please consider whether you are better served by writing two separate articles, but bear in mind the need to avoid duplicate publication. Reports of randomized controlled trials should follow the revised CONSORT statement (Consolidated Standards of Reporting Trials) published in JAMA (2001;285:1987-91) as closely as possible.
Reviews are balanced accounts of all aspects of a particular subject including the pros and cons of any contentious or uncertain aspect. Reviews should not exceed 3000 words, four figures and/or tables, and 30 references, and should include a brief summary of no more than 250 words.
Editorials are articles in which the author expresses an opinion on an aspect of neurointerventional medicine based on published data. They should not exceed 1500 words plus 16 references.
The editors of JNIS commission nearly all the editorials published in the journal. Before spontaneously sending us an editorial, please first consult us about your ideas. This will avoid the disappointment of finding that we have already commissioned an article on a similar topic from someone else.
All JNIS case reports must be submitted on this Word template. The case report will be peer reviewed by the JNIS editors in the usual manner, adhering to the double blind requirements outlined above.
If accepted the article will be published by BMJ Case Reports and then republished by JNIS online and in print.
- You do not have to be a subscriber (Fellow) to BMJ Case Reports to submit to JNIS
- BMJ Case Reports and JNIS are both indexed by Medline (PubMed)
- Republication in JNIS does not constitute duplicate publication
Case reports need to show either an unusual clinical development, and/or a new insight into a well recognised clinical problem. A case report needs to have an educational message and must provide evidence of how the case contributes to our understanding of the condition/treatment.
Case reports should not exceed 1000 words and 10 references, and should include a brief summary of no more than 150 words that will be freely available online. You will be asked for more detailed information on submission, eg, title, authors and affiliations; you can also upload images, multimedia files, etc. Please note that Case Reports should examine between 1 and 3 individual cases; if your manuscript examines 4 or more cases, please submit as a Case Series submission type instead.
You are required to provide proof of consent for publication from each of the patients individually described in your article. We need a signed BMJ consent form from every patient (or guardian), regardless of whether or not you feel that the patient can be identified from the content (text and images). Please note that we cannot accept other consent forms (i.e. from your institution) or verbal consent. If for any reason you are absolutely unable to obtain a signed BMJ Consent Form from one or more of the patients, please contact the Editorial Office before submitting, and our Editorial Assistant will let you know what steps need to be taken in order to ensure that we can still consider your case report.
Similar to case reports, a case series will need to show either an unusual clinical development, and/or a new insight into a well recognised clinical problem. A case series needs to have an educational message and must provide evidence of how the case contributes to our understanding of the condition/treatment.
Case series should not exceed a limit of 3000 words, 4 figures and/or tables, and 30 references, and should provide a structured abstract of no more than 250 words. Please note that case series should not be submitted on the case reports template, and, if accepted, will not be published in BMJ Case Reports – only in JNIS.
As with every submission that contains patient-specific details, you are required to provide proof of consent for publication from each of the patients individually mentioned in your article. We need a signed BMJ consent form from every patient (or guardian), regardless of whether or not you feel that the patient can be identified from the content (text and images). Please note that we cannot accept other consent forms (i.e. from your institution) or verbal consent. If for any reason you are absolutely unable to obtain a signed BMJ Consent Form from one or more of the patients, please contact the Editorial Office before submitting, and our Editorial Assistant will let you know what steps need to be taken in order to ensure that we can still consider your case series.
Letters to the Editor
Letters in response to articles published in JNIS are welcome and should be submitted electronically via the journal website. Contributors should go to the abstract or full text of the article in question. At the top right corner of each article is a “contents box”. Click on the “eLetters: Submit a response to this article” link. Letters relating to or responding to previously published items in the journal will be shown to those authors, where appropriate.
Images that highlight new applications of a diagnostic or therapeutic procedure will be featured in this section as well as brief case studies showing a clinical application or interesting presentation of a clinical condition. Articles should not exceed 250 words, 2 illustrations and 2 references and there should be no more than 3 authors. Submissions that do not adhere to these strict limits will be immediately returned to the author and not enter the peer review system. AVI or MPEG files can be included as data supplements.
You need to provide proof of consent for publication from the patient(s) described in the article. We need written consent from every patient (or guardian) regardless of whether the patient can be identified from the images, preferably using the BMJ consent form (available in 13 languages).
Illustrations and additional material
Black and white images should be supplied as TIFF, GIF, EPS, PowerPoint or high quality JPEG files to a minimum of 300 dpi. Color images should be supplied as TIFF, GIF, EPS, PowerPoint or high quality JPEG files to a minimum of 600 dpi.
Additional figures and tables, methodology, references, video clips, raw data etc, may be published online to supplement the article. If your paper exceeds the word count you should consider if any of the article could be published as a “data supplement”. These files will not be copyedited or typeset.
Patient consent form
Please click here to download a copy of the patient consent form (available in 13 languages).
The BMJ Publishing Group journals are willing to consider publishing supplements to regular issues. Supplement proposals may be made at the request of:
- The journal editor, an editorial board member or a learned society may wish to organise a meeting, sponsorship may be sought and the proceedings published as a supplement.
- The journal editor, editorial board member or learned society may wish to commission a supplement on a particular theme or topic. Again, sponsorship may be sought.
- The BMJPG itself may have proposals for supplements where sponsorship may be necessary.
- A sponsoring organisation, often a pharmaceutical company or a charitable foundation, that wishes to arrange a meeting, the proceedings of which will be published as a supplement.
In all cases, it is vital that the journal’s integrity, independence and academic reputation is not compromised in any way.
When contacting us regarding a potential supplement, please include as much of the information below as possible.
- Journal in which you would like the supplement published
- Title of supplement and/or meeting on which it is based
- Date of meeting on which it is based
- Proposed table of contents with provisional article titles and proposed authors
- An indication of whether authors have agreed to participate
- Sponsor information including any relevant deadlines
- An indication of the expected length of each paper Guest Editor proposals if appropriate
For further information on criteria that must be fulfilled, download the supplements guidelines (PDF).
BMJ is a member of CrossCheck by CrossRef and iThenticate. iThenticate is a plagiarism screening service that verifies the originality of content submitted before publication. iThenticate checks submissions against millions of published research papers, and billions of web content. Authors, researchers and freelancers can also use iThenticate to screen their work before submission by visiting www.ithenticate.com.